Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuphoria Therapeutics (NEUP) Current Assets (2021 - 2025)

Historic Current Assets for Neuphoria Therapeutics (NEUP) over the last 5 years, with Q4 2025 value amounting to $23.4 million.

  • Neuphoria Therapeutics' Current Assets rose 43168.92% to $23.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $23.4 million, marking a year-over-year increase of 43168.92%. This contributed to the annual value of $15.0 million for FY2025, which is N/A changed from last year.
  • Latest data reveals that Neuphoria Therapeutics reported Current Assets of $23.4 million as of Q4 2025, which was up 43168.92% from $14.0 million recorded in Q3 2025.
  • Neuphoria Therapeutics' 5-year Current Assets high stood at $32.5 million for Q4 2021, and its period low was $4.4 million during Q4 2024.
  • For the 5-year period, Neuphoria Therapeutics' Current Assets averaged around $17.6 million, with its median value being $15.0 million (2025).
  • Per our database at Business Quant, Neuphoria Therapeutics' Current Assets tumbled by 5515.06% in 2023 and then skyrocketed by 43168.92% in 2025.
  • Neuphoria Therapeutics' Current Assets (Quarter) stood at $32.5 million in 2021, then dropped by 7.83% to $29.9 million in 2022, then tumbled by 55.15% to $13.4 million in 2023, then tumbled by 67.25% to $4.4 million in 2024, then surged by 431.69% to $23.4 million in 2025.
  • Its Current Assets was $23.4 million in Q4 2025, compared to $14.0 million in Q3 2025 and $15.0 million in Q2 2025.